FAIR VALUE MEASUREMENTS (Details Narrative) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended	3 Months Ended
	Jul. 31, 2019	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Common stock, par value		$ 0.01		$ 0.01
Goodwil		$ 8,433		$ 8,433
Amortization expense		500	$ 1,100
BioPharma Acquisition [Member]
Intangible assets	$ 15,600
Goodwil	8,300	$ 8,400
Identifiable Intangible Assets	$ 7,300
Series B Preferred Stock [Member]
Number preferred stocks on converted basis		7,833,334